MoneyWeek on MSN
Fundsmith underperforms again
Terry Smith’s actively-managed fund returned less than 1% in 2025, trailing the MSCI World Index for the fifth year in a row ...
In 2025, speculative small-cap stocks with no earnings or dividends have sharply outperformed quality peers, driven by a ...
“Even if we are right in diagnosing this move to index funds as one of the causes of our recent underperformance and it is ...
Saudi Arabia’s decision to open its equity market to all foreign investors marks a turning point for global portfolios. Read ...
Hence, OCBC’s three themes for S-REITs in 2026 carry a cautious tone. First, OCBC sees an inflection point for S-REITs’ ...
Aim for broad market exposure, keep it simple and minimize costs. The post This is how I would build a sound ETF portfolio ...
Zacks Investment Research on MSN
Here's why biotech ETFs are rallying hard
Biotech stocks have rallied strongly into 2026, building on the late-2025 momentum from positive clinical data, cheaper valuation, easy money policy and favorable macro conditions. Biotech-based ...
Major stock indexes mostly eased and Treasury yields rose on Thursday ahead of Friday's key U.S. jobs report, while defense company shares jumped amid U.S. President Donald Trump's plans for a $1.5 ...
SINGAPORE: Asian stocks drifted lower and the dollar stood tall on Friday ahead of a crucial jobs report, while investors ...
Global hedge funds' net allocation to Chinese stocks stands at 7.6 percent, lower than the previous peak of 11 percent to 13 ...
NUMBER OF SHARES COMPOSING CURRENT SHARE CAPITAL AND TOTAL NUMBER OF VOTING RIGHTS AS OF 31 DECEMBER 2025 Information about ...
The AI trade is still alive and well. Even with a modest starting investment, Vanguard has the perfect ETF designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results